Autoantibodies Neutralizing Type I IFNs in the Bronchoalveolar Lavage of at Least 10% of Patients During Life-Threatening COVID-19 Pneumonia
Interferon Type I
Humans
COVID-19
Interferon-alpha
Original Article
Bronchoalveolar Lavage
Autoantibodies
DOI:
10.1007/s10875-023-01512-9
Publication Date:
2023-05-20T12:02:07Z
AUTHORS (68)
ABSTRACT
Abstract Autoantibodies (auto-Abs) neutralizing type I interferons (IFNs) are found in the blood of at least 15% unvaccinated patients with life-threatening COVID-19 pneumonia. We report here presence auto-Abs IFNs bronchoalveolar lavage (BAL) 54 415 (13%) pneumonia tested. The individuals BAL included 45 (11%) against IFN-α2, 37 (9%) IFN-ω, IFN-α2 and/or ω, and five (1%) IFN-β, including three (0.7%) two (0.5%) IFN-β. Auto-Abs also neutralize other 12 subtypes IFN-α. Paired plasma samples were available for 95 patients. All seven paired who had detectable plasma, one patient only blood. are, therefore, present alveolar space 10% These findings suggest that these impair IFN immunity lower respiratory tract, thereby contributing to hypoxemic
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (47)
CITATIONS (24)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....